MENU
WGO
Back to Top
World Gastroenterology Organisation
World Gastroenterology Organisation
Follow
WGO: Facebook WGO: Twitter
Share

Acute Hepatitis E

Wasim Jafri, MD, FRCP, FACG, FACP

Wasim Jafri, MD, FRCP, FACG, FACP
Professor and Associate Dean
Department of Medicine and Gastroenterology
Aga Khan University Karachi
Pakistan

   
Om Parkash, MBBS, FCPS, FCPS (GI), MSc, FACP

Om Parkash, MBBS, FCPS, FCPS (GI), MSc, FACP
Aga Khan University Karachi
Pakistan

Background

Hepatitis E virus (HEV) is associated with acute viral hepatitis E, an enterically transmitted hepatitis. HEV is becoming increasingly  recognized in many parts of the world especially in developing countries like south Asia and Africa 1, 2. It is a significant worldwide public health problem with estimated infected cases of HEV amounting to about one third of the world population 3.

The first outbreak of HEV occurred in New Delhi (India) in 1955-56; this was retrospectively confirmed and reported that approximately 29,000 cases had jaundice 4. Subsequently, many epidemics have been reported from other parts of the world such as parts of Asia, Mexico and Africa 2. Moreover, a sporadic form of acute HEV infection occurred in developing parts of Asia and Africa as well as in developed nations 5.

Hepatitis E virus (HEV) is a non-enveloped, single-stranded, positive-sense RNA virus classified as a member of Hepeviridae family 6. This family also includes closely related viruses that infect pigs, rabbits, rats, deer and mongoose, which belong to the same genus as the human  HEV genus 7. HEV genome is arranged in three overlapping open reading frames (ORF) i.e. ORF 1, 2, 3 2.

Epidemiology

There are at least four genotypes (1-4) found globally as shown in Table 1 and Figure 1 8, 9. There are clear differences in the epidemic potential of various genotypes, and epidemics occur exclusively in underdeveloped regions where the predominant circulating human strain is HEV genotype 1 (Table 2) 2. Incubation period for HEV infection among human volunteers following oral ingestion has been 4-5 weeks;  however, in actual epidemics where time of water contamination is known, incubation period varies from 2-10 weeks 9. There are at least four routes of transmission; fecal-oral transmission (most common), foodborne transmission, transfusion of infected blood products, and  vertical transmission. The commonest is fecaloral transmission 9, 10.

 

Table 1 Geographic distribution of HEV genotypes 8

 

Figure 1 Showing HEV endemic regions 9

 

Table 2 Comparison of the Hepatitis E virus by select characteristics 2

 

The epidemiologic features of epidemic hepatitis E have remained unchanged since the first described outbreak from India; highest case rates among young individuals and a high fatality rate among pregnant women; the latter is characteristic of acute HEV infection 2. Different  epidemiologic patterns (sporadic and epidemic) have been noted in countries where disease is either non-endemic or highly endemic; hence, these differ according to routes of transmission, affected population groups and disease characteristics (Table 3) 7, 10.

 

Table 3 Features of HEV infection in highly endemic and non-endemic countries 7

 

Highly Endemic Region

This infection is endemic to tropical and subtropical countries in Asia, Africa and Central America. Outbreaks have been reported from Indian subcontinent including Pakistan mainly from northern areas 7, 11-13. These waves of HEV infections are related to contamination of drinking water with human wastes. Such epidemics had varied from unimodal epidemic lasting a few weeks to multipeaked epidemics which remained for many months with thousands of cases 11, 14. Rain leading either to floods or stagnation of water has been noticed as a main factor for drinking water contamination 14. In these areas, young adults are more affected than children who are mostly asymptomatic and male population is affected more than females. It had also been noted that there is predilection for pregnant women for HEV infection and causing higher mortality in this subset of patients. During pregnancy, HEV infection occurred usually in second or third trimester of pregnancy 7.

It has also been observed over the years that the sporadic form of hepatitis E infection occurs in high endemic areas with same characteristics of age, gender and severity and none of chronic sequelae 7.

From Pakistan two separate HEV isolates (87-Pakistan-A and B) were detected a few years ago 15. Recently an investigative report on an outbreak from southern part of Pakistan was presented, that showed new Pakistani strains 16. Our group has also reported HEV infection  leading to acute liver failure in pregnancy in mid-1990’s 17.

Low endemic regions

These regions include primarily the developed world (including North America and Europe) and some countries of Asia Pacific regions (e.g., Japan, Taiwan, Hong Kong, Australia), where the incidence of HEV infection is quite infrequent. Until very recently it was considered that HEV infection is primarily imported to these places by travelers from high endemic areas to low endemic regions. But in recent past it has been shown that epidemics in low endemic areas like North America as well as in Europe are actually autochthonous as well 9, 18-20. Few  observations have suggested that in these regions HEV infection is caused by zoonotic spread of infection from wild or home animals; in these observations, HEV isolate belong to genotype 3 or 4. These human isolates have been experimentally transmitted to non-human primates 7, 18. A report from Japan has also confirmed that few of the cases had consumed uncooked deer meat and isolates of HEV infection from these cases had similar genomic sequencing to those from wild hog and wild deer 21, 22. Recently from Korea a case series reported that only two patients had a history of travel to India while the remaining cases were supposedly autochthonous with isolation of genotype 4 1.

Clinical manifestations

The clinical features of HEV infection are similar to other acute viral hepatitides; however the majority of HEV infections are asymptomatic. HEV infection manifests in two distinct phases; initial preicteric phase lasting only for few days characterized by fever, loss of appetite, bad  taste in the mouth, vomiting and abdomen pain and second icteric phase lasting for weeks that is marked by the disappearance of prodromal symptoms.

Few patients suffer a prolonged cholestatic phase marked by troublesome itching, though usually with good clinical outcome 7. Clinical outcome of HEV infection in patients with preexisting liver disease or any other comorbid is poor 23. Case fatality rate ranges from 0.5%-4% in hospitalized patients while community based surveys have shown a lower mortality rate 9.

It has also been observed that HEV infection in low endemic areas, usually affects somewhat older people mostly, males with a higher frequency of other comorbid conditions including liver disease and in these areas the outcome of HEV infection in pregnancies is better than  that in high endemic areas 24.

Chronic HEV has been reported in the immunosuppressed (e.g. renal transplant, liver transplant) patients and may lead to cirrhosis 7, 25, 26.

Diagnosis

Specific diagnosis of HEV infection is made on serologic tests for anti HEV antibodies (Ab). Detection of IgM anti HEV Ab suggests current infection while IgG anti HEV shows past exposure. HEV PCR based diagnosis is also available 26, 27. Liver injury is indicated by elevated liver enzymes including transaminases.

Treatment

There is no specific treatment for HEV infection because it is self-resolving infection and only patients with acute liver failure require specific management especially intensive care unit that may require liver transplantation 7, 28.

Prevention

The main mode of prevention would be to break the principal route of transmission (oral-fecal) by providing safe drinking water, proper treatment and safe disposal of human excreta and provision of health education (avoidance of uncooked food/meat, implementation of sanitary food handling practices) to endemic regions 7, 9. Vaccine is currently undergoing extensive trails for prevention and is showing promise 2.

Summary

Initially it was thought that HEV infection is a disease of only underdeveloped countries but now it has been proven that this is also present in the developed world as well. As a consequence this has changed our understanding of its presence. Hence worldwide presence is a major concern because of its association with sporadic infections as well as epidemics. HEV infection has intricate epidemiology with water borne human to human contact and zoonotic transmission.

References

  1. Jeong SH. Current status of hepatitis e virus infection in Korea. Gut Liver. 2011 Dec;5(4):427-31.
  2. Teshale EH, Hu DJ. Hepatitis E: Epidemiology and prevention. World J Hepatol. 2011 Dec 27;3(12):285-91.
  3. WHO. Viral Hepatits. World Health Organization; 2010 [updated 2010; cited 2012 29-01-2012]; Available from: http://apps.who.int/gb/ebwha/pdf_files/A62/A62_22-en.pdf.
  4. Viswanathan R. A review of the literature on the epidemiology of infectious hepatitis. Indian J Med Res. 1957 Jan;45(Suppl.):145-55.
  5. Coursaget P, Buisson Y, N’Gawara MN, Van Cuyck-Gandre H, Roue R. Role of hepatitis E virus in sporadic cases of acute and fulminant hepatitis in an endemic area (Chad). Am J Trop Med Hyg. 1998 Mar;58(3):330-4.
  6. Schlauder GG, Mushahwar IK. Genetic heterogeneity of hepatitis E virus. J Med Virol. 2001 Oct;65(2):282-92.
  7. Aggarwal R, Jameel S. Hepatitis E. Hepatology. 2011 Dec;54(6):2218-26.
  8. Okamoto H. Genetic variability and evolution of hepatitis E virus. Virus Res. 2007 Aug;127(2):216-28.
  9. Aggarwal R, Naik S. Epidemiology of hepatitis E: current status. J Gastroenterol Hepatol. 2009 Sep;24(9):1484-93.
  10. Panda SK, Thakral D, Rehman S. Hepatitis E virus. Rev Med Virol. 2007 May-Jun;17(3):151-80.
  11. Bryan JP, Iqbal M, Tsarev S, Malik IA, Duncan JF, Ahmed A, et al. Epidemic of hepatitis E in a military unit in Abbotrabad, Pakistan. Am J Trop Med Hyg. 2002 Dec;67(6):662-8.
  12. Saeedi MI, Mahmood K, Amanullah, Ziauddin M, Ilyas N, Zarif M. Frequency and clinical course of hepatitis E in tertiary care hospitals. J Coll Physicians Surg Pak. 2004 Sep;14(9):527-9.
  13. Rab MA, Bile MK, Mubarik MM, Asghar H, Sami Z, Siddiqi S, et al. Water-borne hepatitis E virus epidemic in Islamabad, Pakistan: a common source outbreak traced to the malfunction of a modern water treatment plant. Am J Trop Med Hyg. 1997 Aug;57(2):151-7.
  14. Corwin AL, Tien NT, Bounlu K, Winarno J, Putri MP, Laras K, et al. The unique riverine ecology of hepatitis E virus transmission in South-East Asia. Trans R Soc Trop Med Hyg. 1999 May-Jun;93(3):255-60.
  15. He J. Molecular detection and sequence analysis of a new hepatitis E virus isolate from Pakistan. J Viral Hepat. 2006 Dec;13(12):840-4.
  16. Khan A, Tanaka Y, Kurbanov F, Elkady A, Abbas Z, Azam Z, et al. Investigating an outbreak of acute viral hepatitis caused by hepatitis E virus variants in Karachi, South Pakistan. J Med Virol. 2011 Apr;83(4):622-9.
  17. Hamid SS, Jafri SM, Khan H, Shah H, Abbas Z, Fields H. Fulminant hepatic failure in pregnant women: acute fatty liver or acute viral hepatitis? J Hepatol. 1996 Jul;25(1):20-7.
  18. Kwo PY, Schlauder GG, Carpenter HA, Murphy PJ, Rosenblatt JE, Dawson GJ, et al. Acute hepatitis E by a new isolate acquired in the United States. Mayo Clin Proc. 1997 Dec;72(12):1133-6.
  19. Dalton HR, Stableforth W, Thurairajah P, Hazeldine S, Remnarace R, Usama W, et al. Autochthonous hepatitis E in Southwest England: natural history, complications and seasonal variation, and hepatitis E virus IgG seroprevalence in blood donors, the elderly and patients with chronic liver disease. Eur J Gastroenterol Hepatol. 2008 Aug;20(8):784-90.
  20. Erker JC, Desai SM, Schlauder GG, Dawson GJ, Mushahwar IK. A hepatitis E virus variant from the United States: molecular characterization and transmission in cynomolgus macaques. J Gen Virol. 1999 Mar;80 ( Pt 3):681-90.
  21. Tei S, Kitajima N, Takahashi K, Mishiro S. Zoonotic transmission of hepatitis E virus from deer to human beings. Lancet. 2003 Aug 2;362(9381):371-3.
  22. Takahashi K, Kitajima N, Abe N, Mishiro S. Complete or near-complete nucleotide sequences of hepatitis E virus genome recovered from a wild boar, a deer, and four patients who ate the deer. Virology. 2004 Dec 20;330(2):501-5.
  23. Kumar A, Aggarwal R, Naik SR, Saraswat V, Ghoshal UC, Naik S. Hepatitis E virus is responsible for decompensation of chronic liver disease in an endemic region. Indian J Gastroenterol. 2004 Mar-Apr;23(2):59-62.
  24. Mansuy JM, Peron JM, Abravanel F, Poirson H, Dubois M, Miedouge M, et al. Hepatitis E in the south west of France in individuals who have never visited an endemic area. J Med Virol. 2004 Nov;74(3):419-24.
  25. Meng XJ. Recent advances in Hepatitis E virus. J Viral Hepat. 2010 Mar;17(3):153-61.
  26. Halac U, Beland K, Lapierre P, Patey N, Ward P, Brassard J, et al. Chronic hepatitis E infection in children with liver transplantation. Gut. 2011 Nov 23.
  27. Vasickova P, Kralik P, Slana I, Pavlik I. Optimisation of a triplex real time RT-PCR for detection of hepatitis E virus RNA and validation on biological samples. J Virol Methods. 2011 Dec 22.
  28. Bernal W, Auzinger G, Dhawan A, Wendon J. Acute liver failure. Lancet. 2010 Jul 17;376(9736):190-201.